News
March 28, 2020

Regenstrief researcher recognized during celebration of women

Regenstrief research scientist Nicole Fowler, PhD, was recognized as an outstanding woman of inspiration during an event organized by the Indiana Historical Society. The event, A Toast to NOW (Network of Outstanding Women), celebrated women and connected current female leaders with future leaders.

Dr. Fowler and about a dozen other women were recognized for their leadership and contributions to the community.
Dr. Fowler and other award winners

Dr. Fowler is the associate director of the Indiana University Center for Aging Research at Regenstrief as well as an assistant professor of medicine at IU School of Medicine. Through her research, she works to improve the quality of life for older adults with Alzheimer’s disease and their family caregivers. She is especially focused on supporting caregivers in medical decision making. Her work was recently referenced in recommendations made by an influential task force.

In addition to recognizing the women of inspiration, the event featured a panel discussion with female business leaders and allowed guests to network and tour the Women’s Suffrage Exhibit. The event also celebrated the 100th anniversary of the 19th Amendment.

The Indiana Historical Society hosted the event with the goal of establishing a platform where women can form connections with each other, share experiences and develop new skills for success.

Related News

(From left to right) Dr. Brian Dixon, Dr. Sanji De Sylva and Isaac Vetter. Photo credit: Svetlana Efimova

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time